BioUtah, Utah’s trade association for the life sciences community, has opened early bird registration for its 2025 Utah Life Sciences Summit, presented by Mayer Brown. The event, scheduled for November 12 at the Hilton Salt Lake City Center, offers reduced pricing until October 17. The summit attracts over 500 registrants, convening top life sciences leaders, experts, policymakers, and professionals to discuss industry dynamics, regulatory landscapes, market trends, and strategies for innovation and healthcare advancement.
“From groundbreaking startups to established industry leaders, this flagship event brings together the best and the brightest in our sector for a day of discovery, collaboration, and inspiration,” said Kelvyn Cullimore, president and CEO of BioUtah. Utah has emerged as one of the nation’s fastest-growing life sciences hubs, contributing $22.6 billion to the state’s GDP and supporting approximately 180,000 jobs.
The summit’s keynote speakers include Melissa Holyoak, Commissioner of the Federal Trade Commission, a Utahn and nationally recognized lawyer with expertise in consumer protection, constitutional law, healthcare market competition, and mergers and acquisitions. Michelle Tarver, MD, PhD, Director of the FDA’s Center for Devices and Radiological Health, will hold a virtual FDA Town Hall discussion on the agency’s policy priorities and regulatory initiatives. Peter Marks, MD, former head of the FDA’s Center for Biologics Evaluation and Research, oversaw the expansion of FDA-approved cell and gene therapies and played a key role in Operation Warp Speed. Carter Dredge, Executive Director of the Intermountain Health Institute, is a global healthcare thought leader who partners with top thinkers to create novel solutions.
The summit features dedicated networking during lunch, designed to facilitate meaningful professional connections. It also includes subject-specific tracks on workforce, market access, regulatory and quality, and legal. Throughout the day, BioUtah will present awards to individuals and companies for their contributions to life sciences. “Whether your focus is medical device manufacturing, diagnostics, or biopharmaceuticals, you'll find relevant and engaging content at the summit,” said Cullimore. For more details, view the preliminary agenda here and register for early bird discounts here.
